Seeking Alpha

Jarlaxe

Jarlaxe
Send Message
View as an RSS Feed
View Jarlaxe's Comments BY TICKER:
Latest  |  Highest rated
  • Small-Cap Biotechs That Could Make Big Moves This Week [View article]
    STSI Short volume increase,be careful: http://bit.ly/TMQYB1
    Dec 10 09:51 PM | Likes Like |Link to Comment
  • Antares Pharma Explained: Why It's The Best Small Cap Long Term Investment In The Market [View article]
    Thanks again Scott.Its a bargain price now,glad to add more shares at those prices,we will see 5$ in 1month, and 6-7$ end of year.
    Aug 13 08:27 AM | 1 Like Like |Link to Comment
  • Obagi Will Still See An Acquisition Soon: Here's Why [View article]
    Buy Upgrade by Zacks: http://bit.ly/NlCG7m
    Aug 7 10:06 AM | 2 Likes Like |Link to Comment
  • Amarin Has Significant Upside Potential [View article]
    Good news,AMRN European patents: http://bit.ly/OWr2D3
    Aug 7 08:50 AM | 1 Like Like |Link to Comment
  • Why Zalicus Looks Ready For A Bullish Move [View article]
    Buy AMRN,European patents: http://bit.ly/OWr2D3
    Aug 7 08:28 AM | 1 Like Like |Link to Comment
  • Obagi Will Still See An Acquisition Soon: Here's Why [View article]
    Thanks for article as always Scott,Obagi its a good company with a great potential with or without buyout.We will see in few months for sure.
    Aug 7 08:22 AM | 1 Like Like |Link to Comment
  • Debt Burden Makes Horizon Pharma An Attractive Short [View article]
    Approval !HAHAHAHAHAHAHA
    Jul 26 04:18 PM | Likes Like |Link to Comment
  • Seeking Alpha From 3 Obesity Treatment Players [View article]
    VVUS is a fiasco
    Jul 19 03:15 PM | Likes Like |Link to Comment
  • Vivus Gets FDA Approval For Obesity Pill Qsymia [View article]
    Phentermine cant be used in Europe for medicinal purposes http://bit.ly/OlOSaT
    Jul 18 02:56 PM | 1 Like Like |Link to Comment
  • Vivus Gets FDA Approval For Obesity Pill Qsymia [View article]
    Phentermine its banned in Europe.So no market for VVUS there.
    Jul 18 06:22 AM | 1 Like Like |Link to Comment
COMMENTS STATS
10 Comments
8 Likes